Clinical Services Designed Around You

Our global and client-focused end-to-end services, processes, and methodologies provide you with a smooth pathway tailored to the ultimate success of your clinical studies. 

As part of Clinigen Group, Clinigen Clinical Supplies Management gives clients the choice between a combined end-to-end offer that supports the full life-cycle of a medicine and our 25+ years of experience in ready-made offerings in clinical trial supplies and biological sample management. Whether we serve as your clinical supplies department or augment your in-house capabilities through our clinical services, we provide one point of contact, one solution, and one contract. 

We tailor our services to meet the exact needs of your clinical trial, which we oversee from start to finish: from logistics planning, comparator sourcing, and inventory control to packaging and labelling and project budgeting. We accommodate every project requirement to help avoid any potential issues, time conflicts, while mitigating costs to further reassure you that the integrity of your study is both time- and cost-efficient.

At Clinigen, we pioneered services such as On-Demand: a revolutionary way of packaging and labelling clinical supplies, upon request. These new solutions give our clients yet another reason to believe in Clinigen Clinical Supplies Management’s long-standing experience and focus on supporting clinical trials. So whether it’s our end-to-end clinical trial services or our ready-made offerings, we have a solution that will work for you. Have a look at some of the case studies that describe how Clinigen Clinical Supplies Management has helped companies like yours manage their clinical trials.

global, Client-focused, Tailored Solutions 

With Clinigen Clinical Supplies Management as your global clinical supplies partner, you can expect reliable and innovative clinical services designed around you that deliver outstanding results.

We’re part of Clinigen’s global network and supply chain, with locations on every continent. With over 80% of the studies we support being multinational, we support clinical trials on a global scale, with key departments like project management and business development operating internationally.

With over 25 years of experience as a dedicated, global clinical trial supplies partner, we maximise your team’s success by providing you with a blend of credible, unique, and traditional services which allow us to reduce costs while shortening timelines for some of the most complex clinical studies in the world.

We manage your clinical supplies through every step of your clinical trial – even in cases of unexpected changes. This means clear and concise communication from us to you, throughout the duration of the clinical trial timeline, thereby providing both managerial and operational excellence that is visibly applied in our everyday methods.

With flexibility and agility at our very core, every study receives our undivided attention. We quickly react to client requests and can easily handle large international Phase III studies. But unlike our competitors, we’re also nimble enough to provide quick turnarounds, creating customised services for our client’s exact needs in the ever-changing environment of clinical studies.

Since 1997, we have been committed to offering our clients a dynamic range of fully integrated logistics services for their clinical trials. This works to ensure accuracy and efficiency during each stage of the clinical trial supply chain process.

Post-trial: Maintaining treatment access through Managed Access Programmes

At Clinigen, we get life-saving medicines to those who need them. When a clinical trial is complete, and the sponsor company has the required data available, the company still has an obligation to the patients who took part in the trial. As laid out in the Declaration of Helsinki, clinical trial sponsors, researchers and host country governments have a duty to ensure that all participants in clinical trials have post-trial access to treatments identified as beneficial during the trial. Considering the often substantial lag time between regulatory approval and commercial availability in certain countries, pharmaceutical and biotech companies need to plan early.

Clinigen’s Managed Access Programmes (MAPs) can cost-effectively meet patient access obligations and release internal resources. As pioneers in early access and compassionate use, with more than 30 years’ experience across 100+ countries, we work in partnership with pharma companies to design and implement MAPs that serve our clients and help treat patients. Clinigen’s flexible approach and industry-leading experience mean that our clients get the right solution – and patients get the right medicine.

Get in touch with our Managed Access team to learn more.